Senseonics, a company out of Germantown, Maryland, won FDA approval for its Eversense continuous glucose monitoring system. The system is intended to be used instead of traditional fingerprick tests to make diabetes-related decisions. This is a giant step for the company, which has developed a technology that combines a tiny implant with a wearable transmitter to continuously measure glucose for 90 days at...
Tag: <span>Glucometer</span>
Post
Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes
July 17, 2018 by Carmen Heredia Rodriguez, Kaiser Health News For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on an assortment of expensive medicines and devices to stay healthy. Test strips. Needles. A glucose meter. Insulin. Credit: CC0 Public Domain The increasing cost of Type 1 diabetes, one of the most common...
Post
Eversense Implantable Glucometer Keeps Tabs on Blood Sugar Continuously for 3 Months
Senseonics, a company based in Germantown, Maryland, won FDA approval for its Eversense continuous glucose monitoring system. This is the first implantable, long term blood sugar monitor that can be used for up to three months at a time. The technology relies on a small device that’s implanted under the skin of the upper arm. A...
Post
Dexcom G6 Continuous Glucometer Doesn’t Require Finger Pricks
Dexcom landed FDA clearance under the de novo classification process for its Dexcom G6 continuous glucose monitor, which can be used as a standalone monitor or as a part of an automated insulin delivery system. The neatest feature of the Dexcom G6 is that the sensor doesn’t require calibration and so pricking the finger can be a thing...